CD30 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD30 CAR-T therapy, covering 2025-02-27 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma [NA]